In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor

22Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A series of thirty-four diarylpentanoids derivatives were synthesized and evaluated for their α-glucosidase inhibitory activity. Eleven compounds (19, 20, 21, 24, 27, 28, 29, 31, 32, 33 and 34) were found to significantly inhibit α-glucosidase in which compounds 28, 31 and 32 demonstrated the highest activity with IC50 values ranging from 14.1 to 15.1 µM. Structure-activity comparison shows that multiple hydroxy groups are essential for α-glucosidase inhibitory activity. Meanwhile, 3,4-dihydroxyphenyl and furanyl moieties were found to be crucial in improving α-glucosidase inhibition. Molecular docking analyses further confirmed the critical role of both 3,4-dihydroxyphenyl and furanyl moieties as they bound to α-glucosidase active site in different mode. Overall result suggests that diarylpentanoids with both five membered heterocyclic ring and polyhydroxyphenyl moiety could be a new lead design in the search of novel α-glucosidase inhibitor.

Cite

CITATION STYLE

APA

Leong, S. W., Abas, F., Lam, K. W., & Yusoff, K. (2018). In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor. Bioorganic and Medicinal Chemistry Letters, 28(3), 302–309. https://doi.org/10.1016/j.bmcl.2017.12.048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free